Skip to main content

Outlook Therapeutics, Inc. (OTLK) Stock

Outlook Therapeutics, Inc. Stock Details, Movements and Public Alerts

Stock Details

Outlook Therapeutics, Inc. (OTLK), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $0.98. Over the past 52 weeks, it has ranged between $0.16 and $3.39. This places the current price at 28.9% of its 52-week high and 508.7% above its 52-week low. Recent trading volume was recorded at 1,342,241. The 14-day Relative Strength Index (RSI) stands at 40.19, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $1.19 by 17.65%. Similarly, it is above its 200-day moving average of $0.94 by 4.26%. The MACD histogram is -0.08, indicating bearish momentum (MACD Line: -0.06, Signal Line: 0.02).

52-Week Range

$3.39 - $0.16

-71.09% from high · +508.70% from low

Avg Daily Volume

14,809,901

20-day average

100-day avg: 15,337,167

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-6.50

EV/EBITDA

-2.40

EPS (TTM)

-$1.13

Price to Sales

583.77

Beta

0.78

Less volatile than market

Q:How is OTLK valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is OTLK's risk profile compared to the market?
With a beta of 0.78, Outlook Therapeutics, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-11006.82%

EBITDA

$-60,454,584

Return on Assets

-184.82%

Q:How profitable and efficient is OTLK's business model?
0 The operating margin of -11006.82% reveals how efficiently the company runs its core business operations before interest and taxes.
Q:What are OTLK's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$194.5M

Revenue (TTM)

$333,141

Revenue/Share (TTM)

$0.01

Shares Outstanding

187.00M

Book Value/Share

-$0.28

Asset Type

EQUITY

Q:What is OTLK's market capitalization and position?
Outlook Therapeutics, Inc. has a market capitalization of $194.5M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 187.00M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does OTLK's price compare to its book value?
Outlook Therapeutics, Inc.'s book value per share is -$0.28, while the current stock price is $0.98, resulting in a price-to-book (P/B) ratio of -3.54. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$5.40

451.02% upside potential

Analyst Recommendations

Strong Buy

0

Buy

2

Hold

1

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for OTLK?
3 analysts cover OTLK with 67% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $5.40 implies 451.0% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on OTLK?
Current analyst recommendations:02 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 31, 2026, 02:26 AM

Technical Indicators

RSI (14-day)

40.19

Neutral

50-Day Moving Average

$1.19

-17.65% below MA-50

200-Day Moving Average

$0.94

4.26% above MA-200

MACD Line

-0.06

MACD Signal

0.02

MACD Histogram

-0.08

Bearish

Q:What does OTLK's RSI value tell investors?
The RSI (Relative Strength Index) for OTLK is currently 40.19, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret OTLK's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.06 below the signal line at 0.02, with histogram at -0.08. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.19) is above the 200-day MA ($0.94), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently between the MAs, suggesting transition.

Indicators last updated: Jul 31, 2026, 12:41 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for OTLK and get notified when the price changes.

Stay Ahead of the Market with Outlook Therapeutics, Inc. Alerts

Set up price alerts for Outlook Therapeutics, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.